Table 3.
Anterior MI (n=222) | Inferior MI (n=243) | p | ||
---|---|---|---|---|
Vessel disease | 1-vessel n (%) | 103 (46.4) | 120 (49.4) | 0.42 |
2-vessel n (%) | 77 (34.7) | 88 (36.2) | ||
3-vessel n (%) | 42 (18.9) | 35 (14.4) | ||
IRA n (%) | LMCA n (%) | 2 (0.9) | – | – |
LAD n (%) | 220 (99.1) | – | ||
RCA n (%) | – | 222 (91.4) | ||
CFX n (%) | – | 21 (8.6) | ||
Tirofiban use n (%) | 58 (26.1) | 76 (31.3) | 0.22 | |
Reference diameter (mm) | 3.10±0.24 | 3.18±0.54 | 0.02 | |
Postprocedural percent stenosis (%) | 8.98±2.81 | 9.36±2.96 | 0.16 | |
Lesion length (mm) | 17.40±4.18 | 16.87±3.02 | 0.11 | |
ST segment resolution (%) | 82±7 | 77±75 | 0.09 | |
LVEF (%) | 48.37±6.85 | 52.22±6.76 | 0.001 |
MI – Myocardial infarction; IRA – infarct related artery; LVEF – left ventricular ejection fraction. Data are given as mean ±SD or% of the patients.